If you've listened to this podcast before, you already know that we avoid hype, and we stick to talking about evidence-based science. So, let me say right up front — today, the cause of multiple sclerosis is unknown. However, a research team has identified a bacterial toxin that may cause the onset of MS as well as MS relapses.
Joining me for an exclusive conversation about this discovery is Dr. Timothy Vartanian, who leads the team that made the discovery, and Dr. Richard Rudick, whose career has focused on experimental therapeutics for MS, playing a key role in the development of both Avonex and Tysabri.
We're also talking about a stem cell therapy called MSC-NP that, in a Phase 1 clinical trial, delivered positive outcomes among people living with progressive MS.
We'll tell you about a study that demonstrated why EDSS alone does not accurately define an individual's MS journey.
We're sharing news from the International Progressive MS Alliance about a new research pipeline that will focus on improving well-being for people living with progressive MS.
And we'll tell you where you can catch a replay of the International Progressive MS Alliance's latest webcast, Developing Treatments to End MS Progression.
We have a lot to talk about! Are you ready for RealTalk MS??!
This Week: Is this the cause of MS? :22
STUDY: MSC:NP, a stem cell therapy for MS, delivers a positive outcome among people living with progressive MS 1:33
STUDY: Does EDSS tell the whole story of your MS status? 5:03
The International Progressive MS Alliance funds a research pipeline focused on improving well-being among people living with progressive MS 8:42
Webcast Replay: Developing Treatments to End MS Progression 10:24
Dr. Richard Rudick and Dr. Timothy Vartanian discuss a new discovery that may lead scientists to the cause of MS 11:36
Share this episode 29:25
Have you downloaded the free RealTalk MS app? 29:46
SHARE THIS EPISODE OF REALTALK MS
Just copy this link & paste it into your text or email: https://realtalkms.com/292
ADD YOUR VOICE TO THE CONVERSATION
I've always thought about the RealTalk MS podcast as a conversation. And this is your opportunity to join the conversation by sharing your feedback, questions, and suggestions for topics that we can discuss in future podcast episodes. Please shoot me an email or call the RealTalk MS Listener Hotline and share your thoughts!
Phone: (310) 526-2283
And don't forget to join us in the RealTalk MS Facebook group!
If your podcast app doesn't allow you to click on these links, you'll find them in the show notes in the RealTalk MS app or at www.RealTalkMS.com
STUDY: Epsilon Toxin-Producing Clostridium Perfringens Colonize the MS Gut and Epsilon Toxin Overcomes Immune Privilege
STUDY: Mesenchymal Stem Cell-Derived Neural Progenitors Attenuate Proinflammatory Microglial Activation Via Paracine Mechanisms
STUDY: Cognitive Impairment, Fatigue and Depression in Multiple Sclerosis: Is There a Difference Between Benign and Non-Benign MS?
International Progressive MS Alliance: Well-Being in Multiple Sclerosis Research Funding Opportunity
Prioritizing Progressive MS Rehabilitation Research: A Call from the International Progressive MS Alliance
Webcast Replay: Developing Treatments to End MS Progression
Join the RealTalk MS Facebook Group
Download the RealTalk MS App for iOS Devices
Download the RealTalk MS App for Android Devices
Give RealTalk MS a rating and review
Follow RealTalk MS on Twitter, @RealTalkMS_jon, and subscribe to our newsletter at our website, RealTalkMS.com.
RealTalk MS Episode 292
Guests: Dr. Richard Rudick and Dr. Timothy Vartanian
Tags: MS, MultipleSclerosis, MSResearch, MSSociety, RealTalkMS